Intervention Review

Nebulised hypertonic saline for cystic fibrosis

  1. Peter Wark1,*,
  2. Vanessa M McDonald2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 15 APR 2009

Assessed as up-to-date: 30 DEC 2008

DOI: 10.1002/14651858.CD001506.pub3

How to Cite

Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD001506. DOI: 10.1002/14651858.CD001506.pub3.

Author Information

  1. 1

    Level 3 John Hunter Hospital, Respiratory Medicine HMRI, Newcastle, New South Wales, Australia

  2. 2

    John Hunter Hospital, Department of Respiratory and Sleep Medicine, Newcastle, NSW, Australia

*Peter Wark, Respiratory Medicine HMRI, Level 3 John Hunter Hospital, Locked Bag 1 HRMC, Newcastle, New South Wales, NSW 2310, Australia.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 15 APR 2009


Cited in:


This article has been cited by:

  1. 1
    Alan R. Smyth, Scott C. Bell, Snezana Bojcin, Mandy Bryon, Alistair Duff, Patrick Flume, Nataliya Kashirskaya, Anne Munck, Felix Ratjen, Sarah Jane Schwarzenberg, Isabelle Sermet-Gaudelus, Kevin W. Southern, Giovanni Taccetti, Gerald Ullrich, Sue Wolfe, European Cystic Fibrosis Society Standards of Care: Best Practice guidelines, Journal of Cystic Fibrosis, 2014, 13, S23


  2. 2
    J D Chandler, E Min, J Huang, D P Nichols, B J Day, Nebulized thiocyanate improves lung infection outcomes in mice, British Journal of Pharmacology, 2013, 169, 5
  3. 3
    Clinical Veterinary Advisor, 2013,


  4. 4
    Ruth L. Dentice, Mark R. Elkins, Peter T.P. Bye, Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial, Journal of Physiotherapy, 2012, 58, 1, 33


  5. 5
    D. Hubert, M. Le Bourgeois, Atteinte respiratoire de la mucoviscidose de l'enfance à l'âge adulte, Archives de Pédiatrie, 2012, 19, S17


  6. 6
    Joseph Choi, Gary L. Lee, Common Pediatric Respiratory Emergencies, Emergency Medicine Clinics of North America, 2012, 30, 2, 529


  7. 7
    John Gar Yan Chan, Philip Chi Lip Kwok, Paul M. Young, Hak-Kim Chan, Daniela Traini, Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance, Journal of Pharmaceutical Sciences, 2011, 100, 7
  8. 8
    Melvin Wright, Giovanni Piedimonte, Respiratory syncytial virus prevention and therapy: Past, present, and future, Pediatric Pulmonology, 2011, 46, 4
  9. 9
    Jennifer R. Bishop, Odette J. Erskine, Peter G. Middleton, Timing of dornase alpha inhalation does not affect the efficacy of an airway clearance regimen in adults with cystic fibrosis: a randomised crossover trial, Journal of Physiotherapy, 2011, 57, 4, 223


  10. 10
    Karolina Ratajczyk-Pekrul, Katarzyna Tolak-Omernik, Adam J. Sybilski, Zapalenie oskrzelików – skuteczne czy nieskuteczne metody leczenia?, Pediatria Polska, 2010, 85, 4, 388


  11. 11
    Gerard Ryan, Meenu Singh, Kerry Dwan, Inhaled antibiotics for long-term therapy in cystic fibrosis, The Cochrane Library,
  12. 12
    Judith Thornton, Clare S Murray, Mark Elkins, Tiffany Dwyer, Inhaled mannitol for cystic fibrosis, The Cochrane Library,
  13. 13
    Linjie Zhang, Raúl A Mendoza-Sassi, Claire Wainwright, Terry P Klassen, Nebulised hypertonic saline solution for acute bronchiolitis in infants, The Cochrane Library,